FDA Floats Advice For Developing Stimulant Addiction Drugs
The U.S. Food and Drug Administration issued first-of-its kind draft guidance Wednesday to support the development of drugs and biologics for people with moderate to severe addictions to cocaine, methamphetamine and...To view the full article, register now.
Already a subscriber? Click here to view full article